Literature DB >> 2137529

Aromatic L-amino acid decarboxylase is modulated by D1 dopamine receptors in rat retina.

Z L Rossetti1, C P Silvia, D Krajnc, N H Neff, M Hadjiconstantinou.   

Abstract

Aromatic L-amino acid decarboxylase (AAAD) activity of rat retina increases when animals are placed in a lighted environment from the dark. The increase of activity can be inhibited by administering the selective dopamine D1 receptor agonist SKF 38393, but not the selective D2 agonist quinpirole, or apomorphine. Conversely, in the dark, enzyme activity can be enhanced by administering the selective D1 antagonist SCH 23390 or haloperidol, but not the selective D2 antagonist (-)-sulpiride. Furthermore, in animals exposed to room light for 3 h, the D1 agonist SKF 38393 reduced retinal AAAD activity, and this effect was prevented by prior administration of SCH 23390. In contrast, quinpirole had little or no effect when administered to animals in the light. Kinetic analysis indicated that the apparent Vmax for the enzyme increases with little change in the apparent Km for the substrate 3,4-dihydroxyphenylalanine or the cofactor pyridoxal-5'-phosphate. We suggest that dopamine released in the dark tonically occupies D1 receptors and suppresses AAAD activity. When the room light is turned on, D1 receptors are vacated and selective D1 agonists can either prevent the rise of AAAD or reverse light-enhanced AAAD activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137529     DOI: 10.1111/j.1471-4159.1990.tb02320.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

1.  L-Dopa decarboxylase expression profile in human cancer cells.

Authors:  Ioanna Chalatsa; Eleftheria Nikolouzou; Emmanuel G Fragoulis; Dido Vassilacopoulou
Journal:  Mol Biol Rep       Date:  2010-06-11       Impact factor: 2.316

2.  Purification of an endogenous inhibitor of L-Dopa decarboxylase activity from human serum.

Authors:  Alice-Georgia Vassiliou; Dido Vassilacopoulou; Emmanuel G Fragoulis
Journal:  Neurochem Res       Date:  2005-05       Impact factor: 3.996

3.  D2 dopamine receptors in the human retina: cloning of cDNA and localization of mRNA.

Authors:  A Dearry; P Falardeau; C Shores; M G Caron
Journal:  Cell Mol Neurobiol       Date:  1991-10       Impact factor: 5.046

4.  Release of membrane-associated L-dopa decarboxylase from human cells.

Authors:  Ioanna Chalatsa; Emmanuel G Fragoulis; Dido Vassilacopoulou
Journal:  Neurochem Res       Date:  2011-04-11       Impact factor: 3.996

Review 5.  Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme.

Authors:  M D Berry; A V Juorio; X M Li; A A Boulton
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

Review 6.  Dopamine receptor localization in the mammalian retina.

Authors:  J Nguyen-Legros; C Versaux-Botteri; P Vernier
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

7.  The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions.

Authors:  E Scarr; D M Wingerchuk; A V Juorio; I A Paterson
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

8.  Changes in dopa decarboxylase mRNA but not tyrosine hydroxylase mRNA levels in rat brain following antipsychotic treatment.

Authors:  P R Buckland; M C O'Donovan; P McGuffin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Phenylalanine in the caudate nucleus of dopamine depleted rats.

Authors:  P R Paetsch; A J Greenshaw; A V Juorio
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

Review 10.  Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.

Authors:  D D Mousseau
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.